Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

World’s Biggest L-DOPA Production Base Ready For Operation

This article was originally published in PharmAsia News

Executive Summary

Shandong Xinhua Pharmaceutical Co. Ltd. and Sankyo Chemical Industries Ltd. held a completion ceremony for their joint L-380 (drug name L-DOPA) project in Zibo city, Shandong province on Dec. 23. Initial production is to begin in early 2008 with a yearly output of 300 tonnes. The project will be the world's biggest L-380 production base when in full operation. L-DOPA, used for treating Parkinson's disease, is expected to grow at an annual rate of 13 percent globally to reach $2.3 billion by 2010. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065945

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel